title: Rapid vanishing of tumors by withdrawal of methotrexate in Epstein-Barr virus-related B cell lymphoproliferative disorder.
authors.affiliation: Department of Hematology & Oncology, Wakayama Medical University. ketunai@wakayama-med.ac.jp
authors.forename: Shima
authors.initials: S
authors.lastname: Uneda
authors.forename: Takashi
authors.initials: T
authors.lastname: Sonoki
authors.forename: Yashushi
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Matsuoka
authors.forename: Hideki
authors.initials: H
authors.lastname: Nakakuma
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D020031:Epstein-Barr Virus Infections / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007107:Immune System / Q000187:drug effects; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000821:virology*; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D009062:Mouth Neoplasms / Q000175:diagnosis / Q000821:virology*; D013899:Thoracic Neoplasms / Q000175:diagnosis / Q000821:virology*; D014057:Tomography, X-Ray Computed
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate